key: cord-0804282-vm7ln9wy
authors: Pabalan, Noel; Tharabenjasin, Phuntila; Suntornsaratoon, Panan; Jarjanazi, Hamdi; Muanprasat, Chatchai
title: Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis
date: 2020-12-16
journal: Infect Genet Evol
DOI: 10.1016/j.meegid.2020.104682
sha: 26a450cb21142188cd21df5d51aed3cd06f92197
doc_id: 804282
cord_uid: vm7ln9wy

BACKGROUND: The reported association between an insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme (ACE) gene and the risk for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) remains controversial despite the publication of four meta-analyses on this topic. Here, we updated the meta-analysis with more studies and additional assessments that include adults and children within the context of the coronavirus disease 2019 (COVID-19) pandemic. METHODS: Sixteen articles (22 studies) were included. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using three genetic models (allele, recessive and dominant), in which ARDS patients were compared with non-ARDS patients (A1) and healthy controls (A2). Mortality outcomes were also assessed (A3). The influence of covariates was examined by meta-regression. Bonferroni correction was performed for multiple pooled associations. Subgroup analyses based on ethnicity (Asians, Caucasians) and life stage (adults, children) were conducted. Heterogeneity was addressed with outlier treatment. RESULTS: This meta-analysis generated 68 comparisons, 21 of which were significant. Of the 21, four A1 and three A3 highly significant (P(a) = 0.00001–0.0008) outcomes withstood Bonferroni correction. For A1, allele and recessive associations were found in overall (OR 0.49, 95% CI 0.39–0.61), Caucasians (OR 0.46, 95% CI 0.35–0.61) and children (ORs 0.49–0.66, 95% CI 0.33–0.84) analyses. For A3, associations were found in overall (dominant: OR 0.45, 95% CI 0.29–0.68) and Asian subgroup (allele/ dominant: ORs 0.31–0.39, 95% CIs 0.18–0.63) analyses. These outcomes were either robust, or statistically powered or both and uninfluenced by covariates. CONCLUSIONS: Significant associations of the ACE I/D polymorphism with the risk of ALI/ARDS were indicated in Caucasians and children as well as in Asians in mortality analysis. These findings were underpinned by high significance, high statistical power and robustness. ACE genotypes may be useful for ALI/ARDS therapy for patients with COVID-19.

Acute respiratory distress syndrome (ARDS) is a consequence of impaired transport of pulmonary oxygen resulting from acute lung injury (ALI) (Piantadosi and Schwartz, 2004) . A statistically high percentage of ARDS patients are in intensive care units (Hingorani et al., 2015) . Moreover, approximately ~ 35% of ARDS mortality (Ware and Matthay, 2000) results from multiorgan failure (Montgomery et al., 1985) , despite improvements in sepsis management and ventilatory support (Brower et al., 2000) . This level of mortality can be attributed to several predisposing factors that include sepsis or infections by viral pathogens such as novel coronavirus disease 2019 (COVID-19) (Singhal, 2020) . Indeed, up to 42% of patients hospitalized for COVID-19 develop ARDS (Gibson et al., 2020) . ARDS prevalence and incidence vary greatly across countries (Villar et al., 2013) and ethnicities (Linko et al., 2009; Villar et al., 2011) , which may be attributed to both nongenetic and genetic factors.

Genetics have been implicated in the pathogenesis of ARDS (Ware and Matthay, 2000) whereby genes interact with the environment to result in various clinical manifestations, responses to treatment and outcomes among ARDS patients (Rahim et al., 2008) . Examining these genetic factors might help to identify potential therapeutic targets and help lay a foundation to predict ALI/ARDS susceptibility and outcomes (Acosta-Herrera et al., 2014) .

Association studies have been widely used for detecting common, low-penetrant, gene variants that may contribute to the genetic architecture of ARDS (Flores et al., 2008) . Studies on mouse and human models suggest that genetic variation plays a significant role in ARDS.

One such genetic variation is the insertion/deletion (I/D) polymorphism in the angiotensin converting enzyme (ACE) gene located on chromosome 17q23, involving a restriction (Rigat et al., 1990) , suggesting a possible influence on the therapeutic response to ACE inhibitors (Haas et al., 1998) . For example, DD homozygotes have been shown to account for 65% of the observed variance in ACE1 expression, and ID heterozygotes express 31% more ACE1 than II do homozygotes (Gard, 2010) . In addition, high plasma and tissue ACE concentrations have been shown to be associated with the DD genotype (Tiret et al., 1992) . DD homozygote carriers were found to have the highest serum ACE activity compared to carriers of the II homozygote and ID heterozygote genotypes, who exhibit low and intermediate ACE activity, respectively (Rigat et al., 1990; Suehiro et al., 2004) . As the ACE I/D polymorphism is responsible for 20% variance in ACE levels and 50% variance in ACE activity (Rigat et al., 1990) , the impact of this single polymorphism on endpoints such as sepsis and ARDS is considerable (Brugts and Den Uil, 2008) . In sepsis, the DD genotype was found to be associated with a significantly higher mortality rate and worse disease severity (Harding et al., 2002) , and ARDS patients were found to have increased DD genotype frequency and a higher mortality rate (Marshall et al., 2002b) . In adults, higher mortality rates and ARDS prevalence in the intensive care unit population were significantly associated with the DD genotype (Jerng et al., 2006; Marshall et al., 2002a) . In contrast, predominance of the II genotype was significant among premature infants (Sivasli et al., 2007) . Between ethnicities, the DD genotype was prevalent among Asians compared to Caucasian and African populations (Sagnella et al., 1999) . The value of ACE I/D as a genetic marker lies in its association with the risk of a wide range of clinical outcomes that include response to ACE inhibitor therapy (Scharplatz et al., 2004) . Operating on the hypothesis that the ACE I/D polymorphisms is associated with ARDS, we performed the current meta-analysis (with an umbrella review) for four reasons: (i) to obtain less ambiguous, clearer estimates and to update the role of ACE I/D with in ARDS; (ii) to strengthen the evidence with the inclusion of more studies; (iii) to examine associations in J o u r n a l P r e -p r o o f Journal Pre-proof adults and children; and (iv) to evaluate characteristics that might influence summary effects.

This study aims to clarify the impact of ACE I/D in ARDS, which might lead to better prediction of ARDS risk and help manage therapies for COVID-19 patients (Essig et al., 2020) . As recommended by (Matsuda et al., 2012) , we replicated their meta-analysis with larger sample sizes, and/or samples from other populations.

Four databases (PubMed in MEDLINE, Google Scholar, Science Direct and Mednar) were searched for association studies as of April 28, 2020. The terms used were "ACE I/D", "polymorphism", "ARDS", "angiotensin converting enzyme insertion-deletion" and "acute respiratory distress syndrome" as medical subject headings and text and restricted to the English language. The search strings used are summarized in Table S1 . Additional eligible studies were identified from references cited in the retrieved articles.The inclusion criteria were as follows: (i) case-control study design evaluating the association between ACE I/D and ARDS and (ii) sufficient genotype or allele frequency data to allow calculation of odds ratios (ORs) and 95% confidence intervals (CIs). The exclusion criteria were as follows: (i) studies without controls or studies with genotype or allele frequencies that were unusable or absent; (ii) articles that did not cover the polymorphism or disease in question; (iii) reviews;

and (iv) non-English articles.

Two investigators (NP and PT) independently extracted the data that resulted in consensus. 

The Clark-Baudouin scale was used to evaluate the methodological quality of the included studies (Clark and Baudouin, 2006) . In this scale, low, moderate and high scores are < 5, 5-6 and  7, respectively. The Hardy-Weinberg Equilibirum (HWE) was assessed using the application in https://ihg.gsf.de/cgi-bin/hw/hwa1.pl.

Our study design followed that of a previous meta-analysis (Matsuda et al., 2012) 

A flowchart of the study selection process is shown in Fig 1; the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (Moher et al., 2009), a checklist of which is detailed in Table S2 was followed for this study. the initial search resulted in 355 citations retrieved, followed by a series of omissions that eventually yielded 16 articles for inclusion (Adamzik et al., 2007; Cardinal-Fernandez et al., 2013; Çelik et al., 2010; Chan et al., 2005; Cruces et al., 2012; Jerng et al., 2006; Lu et al., 2016; Lu et al., 2011; Marshall et al., 2002a; Plunkett et al., 2008; Salnikova et al., 2013; Satar et al., 2012; Sivasli et al., 2007; Tsantes et al., 2013; Villar et al., 2008; Yimenicioglu et al., 2011) . Eleven articles presented multiple datasets resulting in a total of 13, 7 and 9 studies for A1, A2 and A3, respectively (Table S3) . Table 1 shows which articles were and were not included in the four previous meta-analyses (Deng et al., 2015; Hu et al., 2010; Matsuda et al., 2012; Tsantes et al., 2013) . (Table S3) .

Tables 2 and 3 show 36 and 32 pre-and postoutlier comparisons, of which two (6%) and 19

(59%) were significant, and two (6%) and 15 (47%) had zero to low-level heterogeneity (I 2 = 0%-9%), respectively. Between pre-and postoutlier analyses, the number of fixed-effect outcomes increased from four (11%) to 32 (100%). Overall and HWE-compliant outcomes were not materially different across the genetic models and between pre-and postoutlier analyses. None of the significant outcomes met both conditions for publication bias assessment. Table 4 summarizes the 21 significant pooled ORs, with sample sizes for cases and controls, aggregate statistical power (ASP) and sensitivity treatment outcomes as well as HWE and life stage outcomes. These features were not present in (Matsuda et al., 2012) . (Tables 2 and 4 ). Meta-regression revealed significant linear associations between study quality (P = 0.021) and sample size (P = 0.037) in the recessive Caucasian outcome (Table 5) .

However, the associations did not survive Bonferroni correction.

The mechanism of outlier treatment is presented for the recessive model in the overall analysis of the A1 comparison (Figs 2-4). Fig 2 shows the preoutlier forest plot, with a pooled OR (0.75, 95% CI 0.49-1.15) that was nonsignificant (P a = 0.19) and heterogeneous (P het < 0.00001, I 2 = 75%). The Galbraith plot identified four outliers (Cardinal-Fernandez et al., 2013; Plunkett et al., 2008; Sivasli et al., 2007; Villar et al., 2008) , found above the +2 confidence limit (Fig 3) . In Fig 4, the postoutlier outcome (outlier omitted) showed reduced heterogeneity (P het = 0.23, I 2 = 24%); and gained significance (OR 0.49, 95% CI 0.39-0.61, P a < 0.00001). This operation is numerically summarized in Table 2 . Bonferroni correction, and they were not robust (Table 4) . Table 3 shows 23 A3 comparisons, eight of which were significant, found in all genetic models. Of the eight, three survived Bonferroni correction. One of the three was significant in overall analysis of the dominant model (OR 0.45, 95% CI 0.29-0.68, P a = 0.0002); it was robust and statistically powered (99%). Meta-regression of this low-level heterogeneous (I 2 = J o u r n a l P r e -p r o o f 36%) outcome showed significant linear associations between the age of the subjects (P = 0.028) and the quality of the studies (P = 0.032) on this mortality outcome (Table 5 ) but did not survive Bonferroni correction. The other two comparisons were significant in the Asian subgroup analysis (P a = 0.0001), with zero heterogeneity (I 2 = 0%), and both were robust but underpowered (46.3-73.5%) ( 

Our main findings indicate associations of ACE I/D with ALI/ARDS susceptibility and mortality; the findings are underpinned by high significance, high statistical power, zero to low-level heterogeneity and robustness. Overall, core outcomes were recessive in A1 but not in A3, involving the dominant model. Core subgroup outcomes were Caucasians and children in the allelic/recessive models for A1 and Asians in the allelic/dominant models for A3. The impacts of selection bias and population stratification on the results were likely minimal.

Morover, the outlier-derived core outcomes were unlikely to have been influenced by the study characteristics. Outlier and meta-regression treatments as well as corrective procedures added stability and strength to the findings. These meta-analysis features were not present (by design) in the component single-study outcomes and were unclarified in previous metaanalyses.

The use of healthy controls (A2) is methodologically more powerful than using non-ARDS patients (A1) in associating ACE I/D genotypes with ALI/ARDS (Matsuda et al., 2012) . Nonetheless, the power of A1 in yielding core outcomes was greater than that of A2.

Similarity between the outlier-derived A2 and A1 outcomes in the recessive model was contributed to increasing the evidence for associations. Using A3 (mortality outcome) facilitated comparisons with previous meta-analyses (Matsuda et al., 2012; Tsantes et al., 2013) .

Despite the evidence for associations, the complexity of ALI/ARDS involves interactions between genetic and nongenetic factors allowing for the possibility of environmental involvement. Four of the 16 articles mentioned gene-environment interactions (Adamzik et al., 2007; Salnikova et al., 2013; Tsantes et al., 2013; Villar et al., 2008) and four mentioned haplotypes (Cardinal-Fernandez et al., 2013; Marshall et al., 2002a; Salnikova et al., 2013; Villar et al., 2008) .

We identified six novelties in our study: First, in life stage subgrouping, the childhood stage was implicated in the genetics of ACE I/D-ALI/ARDS associations. Second, outlier treatment generated significance and eliminated heterogeneity. Third, previous nonsignificant (P a > 0.05) comparisons (Matsuda et al., 2012) became significant (P a < 0.05) in our study (Table   4) , likely due to the greater number of studies resulting in elevated ASP. Fourth, an umbrella review of previous meta-analyses (Table S4) 

The ACE I/D polymorphism is posited to have a role in the variable prevalence of COVID-19

infections (Bandyopadhyay et al., 2020) . (Table 4) . A year later (2013), (Tsantes et al., 2013) showed a significant recessive association indicating a two-fold (95% CI 1.16-3.77) risk of death in patients with ALI/ARDS, which concurred with our significant (P a = 0.002) 1.8-fold

finding for the recessive model (95% CI 1.24-2.57) ( Table 4 ). In 2015, a fourth meta-analysis indicated a significant 1.6-fold recessive effect based on 10 articles obtained under high heterogeneity (Deng et al., 2015) . A summary of these four meta-analyses indicates variability in the associative effects of the ACE I/D polymorphism and heterogeneity, both of which have been underexplored.

The limitations of our study include the following: (i) we were unable to examine sex as a factor; and (ii) the pathological conditions of some cases were diluted, whereby ALI/ARDS J o u r n a l P r e -p r o o f comprised only part of the patients' condition. On the other hand, the strengths are as follows: (i) combined sample sizes of the overall sample and subgroups translated to high statistical power in most (14/21: 67%) of the significant comparisons (Table 4 ); (ii) outlier and meta-regression treatments resulted in the core outcomes and minimized bias, respectively; (iii) likelihood of Type 1 and Type II errors were minimized with corrective procedures and statistically powered outcomes, respectively; (iv) six (86%) of the seven Bonferroni-filtered outcomes were robust.

In summary, the ACE I/D polymorphism may be a useful prognostic marker for ALI/ARDS. 

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors

The authors declared that there is no conflict of interest Horizontal lines on either side of each square represent the 95% confidence intervals (CI). The Z test for overall effect was significant (P a < 0.00001). I 2 : a measure of variability expressed in %. The χ2-test shows low-level heterogeneity (Phet = 0.23, I 2 = 24%)

Table S1

Search algorithms Table S2 Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist Table S3 Quantitative features Table S4 Meta-analyses comparisons

None declared

None declared

Additional data are available in the Supplementary Material J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

ALI: acute lung injury; ACE: angiotensin converting enzyme gene; I/D: insertion/deletion; ARDS: acute respiratory distress syndrome; n: number of studies; OR: odds ratio; CI: confidence interval; P a : P-value for association; Phet: P-value for heterogeneity; I 2 : meaure of variability; values in bold indicate significant associations; *survived the Bonferroni correction;  test for interaction between the significant Asian (OR 0.39, P a = 0.0001) and the non-significant Caucasian (OR 1.28, P a = 0.11) effects in the allelic model were significant (PINTERACTION = 0.0004) J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

Assessing the quality of studies supporting genetic susceptibility and outcomes of ARDS

ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS

COVID 19: An Epidemiological and Host Genetics Appraisal

Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome

ACE insertion/deletion polymorphism in sepsis and acute respiratory distress syndrome

ACE: angiotensin converting enzyme gene; ALI: acute lung injury; ARDS: acute respiratory distress syndrome; M: male; F: female; I/D: insertion/deletion polymorphism; * included in the mortality analysis; the Clark-Baudouin scores range from 5 to 9, which places the scores in the moderate to high quality. However, there were more moderate scores ( %) than high scores (44%) with the median (6.0) and interquartile range (5.5-8.5) indicating moderate quality of the studies.J o u r n a l P r e -p r o o f